GreenLight Biosciences is a biotechnology company focused on the sustainable production of chemicals and fuels using its Unconstrained Metabolism ® technology platform. The Company's patented Cell-free Bioprocessing technology offers a sustainable, efficient, clean, and economical way to produce the chemicals commonly used in food, pharmaceuticals, agriculture, and non-petroleum based fuels.
Cell-free Bioprocessing is an unprecedented flexible biomanufacturing platform that preserves the cell's inherent manufacturing capabilities while eliminating the cumbersome need to keep the host organism alive.
|Employees (est.) (Sep 2019)||98||(-1%)|
Greenlight Biosciences total Funding
Greenlight Biosciences latest funding size
Time since last funding
|8 months ago|
Greenlight Biosciences investors
|Khosla Ventures, Baird Capital, Tao Capital Partners, S2G Ventures, Alexandria Venture Investments, Continental Grain Company, Blue I/O, Matthew Walker|
When was Greenlight Biosciences founded?
Greenlight Biosciences was founded in 2008.
Who are Greenlight Biosciences key executives?
Greenlight Biosciences's key executives are Andrey Zarur, Carole Cobb and Marta Ortega-Valle.
How many employees does Greenlight Biosciences have?
Greenlight Biosciences has 98 employees.
Who are Greenlight Biosciences competitors?
Competitors of Greenlight Biosciences include TxCell, M2I Life Sciences and Fluidigm.
Where is Greenlight Biosciences headquarters?
Greenlight Biosciences headquarters is located at 196 Boston Ave, Medford.
Where are Greenlight Biosciences offices?
Greenlight Biosciences has an office in Medford.
How many offices does Greenlight Biosciences have?
Greenlight Biosciences has 1 office.
Receive alerts for 300+ data fields across thousands of companies